Approximate estimation of cell-type resolution transcriptome in bulk tissue through matrix completion

Brief Bioinform. 2023 Sep 20;24(5):bbad273. doi: 10.1093/bib/bbad273.

Abstract

Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for uncovering cellular heterogeneity. However, the high costs associated with this technique have rendered it impractical for studying large patient cohorts. We introduce ENIGMA (Deconvolution based on Regularized Matrix Completion), a method that addresses this limitation through accurately deconvoluting bulk tissue RNA-seq data into a readout with cell-type resolution by leveraging information from scRNA-seq data. By employing a matrix completion strategy, ENIGMA minimizes the distance between the mixture transcriptome obtained with bulk sequencing and a weighted combination of cell-type-specific expression. This allows the quantification of cell-type proportions and reconstruction of cell-type-specific transcriptomes. To validate its performance, ENIGMA was tested on both simulated and real datasets, including disease-related tissues, demonstrating its ability in uncovering novel biological insights.

Keywords: ADMM; cell-type resolution transcriptome estimation; matrix completion; proximal-point algorithm.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Profiling* / methods
  • Humans
  • RNA-Seq / methods
  • Sequence Analysis, RNA / methods
  • Software
  • Transcriptome*